Merit Financial Group, LLC Exact Sciences Corp Transaction History

Merit Financial Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$56.27 - $73.77 $106,969 - $140,236	1,901 Added 60.62%	5,037 $347,000
Q4 2023 Feb 06, 2024	BUY	$59.06 - $75.72 $185,212 - $237,457	3,136 New	3,136 $232,000
Q1 2021 May 18, 2021	SELL	$116.57 - $155.01 $176,370 - $234,530	-1,513 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$99.61 - $142.12 $150,709 - $215,027	1,513 New	1,513 $200,000
Q3 2020 Nov 10, 2020	SELL	$72.92 - $102.01 $423,081 - $591,862	-5,802 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$55.75 - $92.75 $58,035 - $96,552	1,041 Added 21.87%	5,802 $504,000
Q1 2020 May 05, 2020	BUY	$37.9 - $104.44 $180,441 - $497,238	4,761 New	4,761 $276,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Merit Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Merit Financial Group, LLC with notifications on news.